Medical sector is one of the hot spots in recent years, this year is even stronger. Data show that the medical and biological index has reached a cumulative increase of 32.66% during the year, far ahead of other major industry indices. So, what are the leading stocks in the medical sector? Come and learn about it~
1. General pharmaceutical leader:600276 Hengrui Medicine
Hengrui Medicine is a collection of scientific research, production, sales as one of the large-scale pharmaceutical listed companies, is China's largest scientific research and production base of antineoplastic drugs and surgical drugs, is currently China's one of the most innovative large-scale pharmaceutical enterprises. The company's main products include anti-tumor drugs, cardiovascular drugs, surgical drugs, endocrine drugs and so on.
2. Chinese medicine total leader: 000538 Yunnan Baiyao
Yunnan Baiyao Group Co., Ltd. formerly known as Yunnan Baiyao Factory was founded in 1971, is the largest, strongest, best brand of pharmaceutical enterprise groups in Yunnan Province. The company's business includes research, production and sales of chemical raw materials, chemical preparations, proprietary Chinese medicines, Chinese herbal medicines, biological products, health food, cosmetics and beverages; it is also involved in the fields of medical devices and daily chemical products.
3.Blood products leader:002007 Hualan Bio
Hualan Bio, founded in 1992, is a national key high-tech enterprise engaged in the research, development and production of blood products. 1998, Hualan Bio became the first enterprise in China to pass the GMP certification of blood products industry. As a national designated large-scale biological products manufacturer, Hualan Bio has strong technological development strength, leading technology level, first-class production and testing equipment, scientific and standardized management, and perfect quality assurance system, and is in the leading position among domestic enterprises in the same industry.
4. Vaccine leader: 300122 Zhifei Biological
Zhifei Biological is mainly engaged in biotechnology development and management, research, production and sales as one of the high-tech companies. The company distributes A + C meningococcal polysaccharide conjugate vaccine, A + C + Y + W135 meningococcal polysaccharide vaccine, Haemophilus influenzae type B conjugate vaccine, lyophilized live attenuated hepatitis A vaccine, microcard and other products (some of the above products for the exclusive production and sale of the domestic market, there is no competition for similar products in the country). Currently, Zhifei Biologicals' new coronary pneumonia vaccine has been conditionally approved for marketing or emergency use, which marks China's first place in the world in terms of vaccine research and development and industrialization of new coronary pneumonia.
5. Pharmaceutical R&D leader: 603259 WuXi AppTec
We are a company that provides a full range of integrated new drug R&D and production services. The company is committed to promoting the new drug R&D process, and its services cover chemical drug R&D and manufacturing, cell and gene therapy R&D and manufacturing, medical device testing and other fields. WuXi AppTec's empowerment platform is carrying R&D and innovation projects from more than 5,200 partners in more than 30 countries around the world, and is committed to bringing more new and better medicines to patients around the world and realizing the vision of "making the world free of difficult medicines and complicated diseases" as soon as possible.
6. Medical device leader:300760Meridian